SCHEMBL2801193

SCHEMBL2801193

CCC(N)C(=O)OC(=O)[C@@H](N)CCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.52
GRM8 O00222 1/20 0.52
GRM6 O15303 1/20 0.52
GRIN2D O15399 1/20 0.52
GRIN3B O60391 1/20 0.52
GSR P00390 1/20 0.52
GRIK1 P39086 1/20 0.52
GRM5 P41594 1/20 0.52
GRIA1 P42261 1/20 0.52
GRIA2 P42262 1/20 0.52
GRIA3 P42263 1/20 0.52
SLC1A3 P43003 1/20 0.52
SLC1A2 P43004 1/20 0.52
SLC1A1 P43005 1/20 0.52
GRIA4 P48058 1/20 0.52
GRIN1 Q05586 1/20 0.52
GRIN2A Q12879 1/20 0.52
GRIK2 Q13002 1/20 0.52
GRIK3 Q13003 1/20 0.52
GRIN2B Q13224 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29059542 1.00 CYP1A2 (0.52) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL496858 0.90 GRM8 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL4959221 0.90 GRM8 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL10636419 0.88 GRM8 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL3402553 0.85 GABRP (0.52) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL23777420 0.83 SLC1A3 (0.39) GRIK1SLC1A3SLC1A2SLC1A1GRIA4
SCHEMBL3411544 0.82 BLM (0.57) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL1674762 0.82 SLC1A1 (0.54) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL8838342 0.82 CYP1A2 (0.54) CYP1A2GRM8GRM6GRIN2DGRIN3B
SCHEMBL23200441 0.82 CYP1A2 (0.54) CYP1A2GRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2224804-A1 TREATMENT OF CANCER WITH COMBINATIONS OF TOPOISOMERASE INHIBITORS AND PARP INHIBITORS BiPar Sciences, Inc. (US) 2010-09-08 EP disclosed
WO-2009073869-A1 TREATMENT OF CANCER WITH COMBINATIONS OF TOPOISOMERASE INHIBITORS AND PARP INHIBITORS BIPAR SCIENCES, INC. (US) 2009-06-11 WO disclosed
EP-2059498-A2 TREATMENT OF CANCER Bipar Sciences, Inc. (US) 2009-05-20 EP disclosed
WO-2008030883-A2 TREATMENT OF CANCER BIPAR SCIENCES, INC. (US) 2008-03-13 WO disclosed